Compare Eni SpA (E) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eni SpA vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Eni SpA trades at $56.02 (market cap $79.81B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.76 (market cap $6.04B). The key difference: Eni SpA is far larger — about 13.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Eni SpA pays a 4.39% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eni SpA for 53 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| E | IOVA | |
|---|---|---|
Market Cap | $79.81B | $6.04B |
Volume | 365,912 | 14,805,993 |
Sector | Energy | Health |
52-Week High | $57.61 | $14.82 |
52-Week Low | $34.03 | $1.81 |
Typical Hold Time | 53 Days | 0 Days |
Enterprise Value | $104.34B | $5.97B |
Dividend Yield | 4.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $56.02, up 3.82% today, with a bullish technical signal from moving averages and neutral oscillators. The stock shows attractive valuation with a P/E of 12.87 and P/S of 0.85. Recent earnings have been mixed, with Q4 2025 beating estimates but Q1 and Q2 2026 missing. Revenue has declined from $132.5B in 2022 to $82.2B in 2025, though net income margin improved to 5.97% in 2026. Positive news includes expansion in Venezuela, Indonesia, and humanoid robotics partnerships.
Outlook is cautiously optimistic given low valuations and strategic initiatives, but risks include volatile energy prices and execution challenges. Analyst consensus is mixed with 34.6% buy ratings. Earnings growth and operational efficiency are key catalysts for upside, while geopolitical and macroeconomic factors pose headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
